- Wednesday, August 17
- 1:00 PM - 2:00 PM
This clinically focused session will address many important questions regarding the management of elevated triglycerides with the goal of providing practical guidance to manage patients at high CV risk. The expert faculty will compare data on safety, tolerability, and the cardioprotective benefits of the various treatment strategies available.
Understand the key findings of large-scale Omega-3 Fatty Acid clinical trials and how this information relates to clinical practice to reduce ASCVD events
Apply recent clinical trial evidence of EPA on a case-basis for patients on statins, with established CVD and/or at risk of further CV events
Identify barriers to the implementation of effective, long-term management of ASCVD